Anthea Peters

Area of Study / Keywords

Post-transplant lymphoproliferative disorder Solid organ transplant biomarker lymphoma diffuse large B cell lymphoma immunosuppression prognostic factors Epstein-Barr virus chronic lymphocytic leukemia follicular lymphoma clinical trials

---

About

I am an adult hematologist currently appointed as Assistant Professor in the Division of Hematology, Department of Medicine, and cross appointed to the Department of Oncology. I obtained a Master's of Science in Medical Genetics at the University of Alberta (2003), followed by a Medical Degree at the University of Saskatchewan (2006), residency training at the University of Alberta (Internal Medicine 2006-2009) and the University of Calgary (Hematology 2009-2011), and a fellowship in lymphoma at the University of Calgary (2011-2012). My clinical and research interests centre around lymphoproliferative malignancies in adults. 

Clinical Interests

My clinical interests closely align with my research interests. I am a local and regional expert inpost-transplant lymphoproliferative disorders (PTLD) after solid organ transplant having treated most adult PTLD patients in Edmonton since 2012 and having developed provincial guidelines for clinical management. I also treat patients with most lymphoid malignancies, including chronic lymphocytic leukemia, Hodgkin and non-Hodgkin lymphoma, and hairy cell leukemia at the Cross Cancer Institute and the University of Alberta Hospital.  

---

Research

I conduct clinical and collaborative biomedical research in lymphoproliferative disease. I have developed a registry for Alberta patients diagnosed with post-transplant lymphoproliferative disorder (PTLD) following solid organ transplant and am working on several clinical research projects utilizing this resource, including collaborative work with other major transplant centres in Canada. My most recent research grant investigates a rapid novel technique for predicting results of FISH, a molecular test currently used to identify high risk patients with diffuse large B cell lymphoma, as a means to expedite patient care and save public health care dollars. I am also an investigator in several interventional clinical trials conducted at the Cross Cancer Institute and the University of Alberta Hospital for patients with non-Hodgkin and Hodgkin lymphoma, chronic lymphocytic leukemia, and cold agglutinin disease.  

Research Grants

Currently active:

University Hospital Foundation Medical Research Competition 2017

Title: “Novel MYC Immunohistochemistry Classifier to Predict MYC Translocation by Fluorescence In Situ Hybridization in Diffuse Large B Cell Lymphoma”

Role: Principal Investigator

Total Budget: CAN$: 35,000

Completed:

Alberta Innovates Health Solutions (AIHS) Collaborative Research and Innovation Opportunities (CRIO) Project – Cancer 201301 Competition

Title: “Improving the Prevention, Diagnosis, and Treatment of Post-

Transplant Lymphoproliferative Disorders after Solid Organ Transplantation

Using Peripheral Blood and Tissue Biomarkers”

Role: Collaborative Co-Lead

Total Budget: CAN$: 737,363

Bozorgmehr N., Hnatiuk M., Peters A.C., Elahi S.

Experimental Hematology & Oncology. 2023 December; 12 (1) 10.1186/s40164-023-00375-5

---

Peters A., Taparia M.

Lancet Haematology. 2023 May; 10 (5):e311-e312 10.1016/S2352-3026(23)00061-3

---

BRITISH JOURNAL OF HAEMATOLOGY. 2023 May; doi.org/10.1111/bjh.18879

---

Puckrin R., Chua N., Chin K., Peters A., Duggan P., Shafey M., Storek J., Jamani K., Owen C., Stewart D.

BRITISH JOURNAL OF HAEMATOLOGY. 2023 April; 201 (2):319-325 10.1111/bjh.18640

---

Peters A., Keating M.M., Nikonova A., Doucette S., Prica A.

Current Oncology. 2023 February; 30 (2):1745-1759 10.3390/curroncol30020135

---

Puckrin R., Peters A.

CLINICAL TRANSPLANTATION. 2023 February; 37 (2) 10.1111/ctr.14910

---

Puckrin R., Owen C., Fontaine A., Peters A., Stewart D., Shafey M.

BONE MARROW TRANSPLANTATION. 2023 January; 10.1038/s41409-023-01978-6

---

Nowakowski G.S., Yoon D.H., Mondello P., Joffe E., Peters A., Fleury I., Greil R., Ku M., Marks R., Kim K., Zinzani P.L., Trotman J., Sabatelli L., Waltl E.E., Winderlich M., Sporchia A., Kurukulasuriya N.C., Cordoba R., Hess G., Salles G.

ANNALS OF HEMATOLOGY. 2023 January; 10.1007/s00277-023-05196-4

---

Nowakowski, G.S., Yoon, D.H., Peters, A., Mondello, P., Joffe, E., Fleury, I., Greil, R., Ku, M., Marks, R., Kim, K., Zinzani, P.L., Trotman, J., Huang, D., Waltl, E.E., Winderlich, M., Kurukulasuriya, N.C., Ambarkhane, S., Hess, G., Salles, G.

CLINICAL CANCER RESEARCH. 2022 June; 10.1158/1078-0432.CCR-21-3648

---

Stubbins R.J., Lam R., Zhu J., Ghosh S., Mabilangan C., Kuruvilla J., Goswami R.S., Lai R., Preiksaitis J.K., Jain M.D., Peters A.C.

Clinical Lymphoma Myeloma & Leukemia. 2022 May; 10.1016/j.clml.2022.05.006

---

American Society of Hematology. 2021 November; https://doi.org/10.1182/blood-2021-148302

---

American Society of Hematology. 2021 November; https://doi.org/10.1182/blood-2021-146001

---

Puckrin R., Ghosh S., Peters A., Stewart D.

LEUKEMIA & LYMPHOMA. 2021 October; 63 (3):583-590 10.1080/10428194.2021.1992762

---

Society of Hematologic Oncology. 2021 September;

---

Puckrin R., El Darsa H., Ghosh S., Peters A., Owen C., Stewart D.

AMERICAN JOURNAL OF HEMATOLOGY. 2021 July; 96 (7):764-771 10.1002/ajh.26181

---

Huang Y.H., Almowaled M., Li J., Venner C., Sandhu I., Peters A., Lavasanifar A., Lai R.

CURRENT ISSUES IN MOLECULAR BIOLOGY. 2021 June; 43 (1):313-323 10.3390/cimb43010026